JNJ

JOHNSON & JOHNSON

JNJ·478160104·US·Common Stock·Healthcare - Drug Manufacturers - General-13D/G

JNJ (JOHNSON & JOHNSON) is held by 376 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($53.9B), VANGUARD CAPITAL MANAGEMENT LLC ($39.9B), STATE STREET CORP ($34B). Net institutional sentiment: Mixed. In Q2 2026, 11 members of Congress and 185 funds bought JNJ.

376
Holders
(40 Elite)
$405.5B
Total Value
50% (373)
Consensus
185 buying - 188 selling
13F: Insider & Congress: Updated regularly
JNJ

Smart Money Verdict

View all
Loading verdict
Held by 376 funds
40 elite

Who's Trading

Source dates: Price Sep 1, 2026 · Insiders Aug 18, 2026 · Activists May 1, 2026 · Congress Aug 14, 2026

InsiderTLTaubert Jennifer LSell $4.0MAug 17, 2026
InsiderTLTaubert Jennifer LExercise 15K shAug 17, 2026
CongressRich McCormickRich McCormickSale $1,001 - $15,000Jul 30, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
212.1M(-0.6%)$53.9B0.8%+89.14%
0
Increased
157.2M(+0.4%)$39.9B0.9%+10.81%
45
Increased
133.8M(+0.2%)$34B1.0%+83.43%
50
Increased
64.4M(+1.4%)$16.3B0.7%+10.76%
45
Decreased
58.3M(-7.6%)$15.1B0.8%+58.36%
0
Decreased
59.1M(-0.1%)$15B0.8%+105.05%
0
Increased
44.8M(+0.2%)$11.4B0.6%+90.14%
45
Unchanged
31.6M$8B5.5%+156.91%
0
Decreased
28.8M(-1.8%)$7.3B0.9%+124.81%
0
Decreased
23.4M(-8.2%)$6B0.4%+87.12%
0
Decreased
22.6M(-8.8%)$5.7B0.2%+51.12%
0
Increased
22.6M(+12.5%)$5.7B1.0%+60.80%
51
Decreased
21.7M(-0.6%)$5.5B0.9%+88.97%
0
Increased
19.7M(+9.2%)$5B0.4%+57.34%
42
Decreased
19.3M(-0.3%)$4.9B1.0%+115.82%
0
Decreased
19.1M(-0.3%)$4.9B0.6%+127.01%
0
Decreased
18.4M(-6.2%)$4.7B0.9%+80.62%
0
Increased
17.4M(+2.6%)$4.4B0.7%+81.86%
46
Increased
15.7M(+4.2%)$4B0.3%+68.22%
40
Increased
15.7M(+8.5%)$4B1.2%+89.96%
55

Showing 1-20 of 396

1 / 20
JNJJNJJOHNSON & JOHNSON

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used